Cardiovascular Risk in Toledo Population
- Conditions
- Cardiovascular Risk FactorCardiovascular Diseases
- Registration Number
- NCT03294369
- Lead Sponsor
- Castilla-La Mancha Health Service
- Brief Summary
This epidemiological and observational study is aimed to assess cardiovascular risk (CVR) by investigating the prevalence of CVR factors (CVRF), target organ damage (TOD) and cardiovascular disease (CVD) in general population of the sanitary area of Toledo.
- Detailed Description
Epidemiological and observational study that is analyzing a sample from the general population aged 18 years or older, randomly selected from a database of sanitary cards stratified by age and gender.
Clinical history, physical examination and complementary tests are being performed.
Total blood and serum samples are being frozen (-85ºC) for future genetic studies. The biobank is currently being registered at the "Virgen de la Salud" hospital of Toledo.
CVR is assessed by SCORE scale calibrated for Spanish population and the Framingham Heart Study scale.
Patients will be periodically visited, with a minimum follow-up of 5 years. Standard statistical analysis will be performed.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 3125
- Subjects aged 18 years or older, randomly selected from a database of health cards stratified by age and gender
- Individulas aged under 18 years.
- Subjects who do not sign the informed consent.
- Subjects that due to different conditions (physical, mental or social) is expected that do not complete the expected follow-up.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Prevalence of cardiovascular disease December 2020 To assess the prevalence of cardiovascular disease
Assess cardiovascular risk of the study population December 2020 Cardiovascular risk will be determined according to SCORE scale calibrated for Spanish population and the Framingham Heart Study scale.
Prevalence of cardiovascular risk factors December 2020 To assess the prevalence of cardiovascular risk factors
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Avenida de Irlanda, 12, 2º A
🇪🇸Toledo, Spain
Avenida de Irlanda, 12, 2º A🇪🇸Toledo, SpainGustavo C Rodriguez-Roca, MD, PhDContact608293478gcrodriguezroca@gmail.comFrancisco J Alonso-Moreno, MD, PhDSub InvestigatorAlejandro Villarin-Castro, MDSub InvestigatorAntonio Segura-Fragoso, MD, PhDSub InvestigatorLuis Rodriguez-Padial, MD, PhDSub InvestigatorJuan Fernandez-Martin, MD, PhDSub InvestigatorCarlos Escobar-Cervantes, MD, PhDSub Investigator